Axiata Bio completed nearly 100 million yuan in Series A financing

Yatong Bio is a R&D and manufacturer of biomedical consumables. The company’s business integrates R&D, production and sales of high-end laboratory consumables, and provides overall solutions and customized services for related consumables. Recently, Yatong Bio completed a round of financing of nearly 100 million yuan. This round of financing was led by Xingze Capital, Wuxi Guolian Xinchuang, Borun Capital, Zhejiang Hongshi, and Kaicheng Capital as the exclusive financial advisor. The funds raised in this round of financing will be mainly used for the automation upgrade of the company’s production lines, while expanding the layout of new product pipelines.

This article is reproduced from:
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment